BR0116945A - Uma preparação para prevenção de restenose - Google Patents
Uma preparação para prevenção de restenoseInfo
- Publication number
- BR0116945A BR0116945A BR0116945-9A BR0116945A BR0116945A BR 0116945 A BR0116945 A BR 0116945A BR 0116945 A BR0116945 A BR 0116945A BR 0116945 A BR0116945 A BR 0116945A
- Authority
- BR
- Brazil
- Prior art keywords
- preparation
- restenosis
- prevention
- active agent
- agent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/08—Materials for coatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
- A61K49/0438—Organic X-ray contrast-enhancing agent comprising an iodinated group or an iodine atom, e.g. iopamidol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
- A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
- A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
- A61K49/0452—Solutions, e.g. for injection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
- A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
- A61K49/103—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being acyclic, e.g. DTPA
- A61K49/105—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being acyclic, e.g. DTPA the metal complex being Gd-DTPA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
- A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
- A61K49/106—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being cyclic, e.g. DOTA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5094—Microcapsules containing magnetic carrier material, e.g. ferrite for drug targeting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
- A61L29/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
- A61L29/18—Materials at least partially X-ray or laser opaque
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Radiology & Medical Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Dermatology (AREA)
- Surgery (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10115740A DE10115740A1 (de) | 2001-03-26 | 2001-03-26 | Zubereitung für die Restenoseprophylaxe |
PCT/DE2001/004782 WO2002076509A2 (de) | 2001-03-26 | 2001-12-20 | Zubereitung für restenoseprophylaxe |
Publications (3)
Publication Number | Publication Date |
---|---|
BR0116945A true BR0116945A (pt) | 2004-03-09 |
BRPI0116945B1 BRPI0116945B1 (pt) | 2015-12-08 |
BRPI0116945B8 BRPI0116945B8 (pt) | 2021-05-25 |
Family
ID=7679661
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0116945A BRPI0116945B8 (pt) | 2001-03-26 | 2001-12-20 | preparado para tratamento local de epitélio hiperproliferativo |
Country Status (23)
Country | Link |
---|---|
US (8) | US7750041B2 (pt) |
EP (4) | EP1372737B8 (pt) |
JP (1) | JP4484432B2 (pt) |
KR (1) | KR100874308B1 (pt) |
CN (5) | CN1899614B (pt) |
AT (6) | ATE334703T1 (pt) |
AU (3) | AU2006222699B2 (pt) |
BR (1) | BRPI0116945B8 (pt) |
CA (1) | CA2442080C (pt) |
CY (4) | CY1105727T1 (pt) |
CZ (1) | CZ299953B6 (pt) |
DE (8) | DE10115740A1 (pt) |
DK (4) | DK1666071T3 (pt) |
ES (4) | ES2289721T3 (pt) |
HK (5) | HK1064296A1 (pt) |
HU (1) | HUP0303598A3 (pt) |
IL (2) | IL157741A0 (pt) |
MX (1) | MXPA03008368A (pt) |
NZ (1) | NZ527825A (pt) |
PL (1) | PL212008B1 (pt) |
PT (4) | PT1372737E (pt) |
WO (1) | WO2002076509A2 (pt) |
ZA (1) | ZA200306806B (pt) |
Families Citing this family (103)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6774278B1 (en) | 1995-06-07 | 2004-08-10 | Cook Incorporated | Coated implantable medical device |
US7947015B2 (en) | 1999-01-25 | 2011-05-24 | Atrium Medical Corporation | Application of a therapeutic substance to a tissue location using an expandable medical device |
US6955661B1 (en) | 1999-01-25 | 2005-10-18 | Atrium Medical Corporation | Expandable fluoropolymer device for delivery of therapeutic agents and method of making |
DE10115740A1 (de) | 2001-03-26 | 2002-10-02 | Ulrich Speck | Zubereitung für die Restenoseprophylaxe |
EP2324866B1 (en) * | 2002-07-12 | 2014-06-18 | Cook Medical Technologies LLC | Angioplasty balloons drug-coated in an expanded condition |
DE10244847A1 (de) * | 2002-09-20 | 2004-04-01 | Ulrich Prof. Dr. Speck | Medizinische Vorrichtung zur Arzneimittelabgabe |
US8021331B2 (en) | 2003-09-15 | 2011-09-20 | Atrium Medical Corporation | Method of coating a folded medical device |
WO2005027996A2 (en) | 2003-09-15 | 2005-03-31 | Atrium Medical Corporation | Application of a therapeutic substance to a tissue location using an expandable medical device |
EP1663345A2 (en) * | 2003-09-15 | 2006-06-07 | Atrium Medical Corporation | Application of a therapeutic substance to a tissue location using a porous medical device |
US9278015B2 (en) * | 2003-10-16 | 2016-03-08 | Minvasys | Catheter system for stenting and drug treatment of bifurcated vessels |
US20070027523A1 (en) * | 2004-03-19 | 2007-02-01 | Toner John L | Method of treating vascular disease at a bifurcated vessel using coated balloon |
US8431145B2 (en) * | 2004-03-19 | 2013-04-30 | Abbott Laboratories | Multiple drug delivery from a balloon and a prosthesis |
US7989490B2 (en) * | 2004-06-02 | 2011-08-02 | Cordis Corporation | Injectable formulations of taxanes for cad treatment |
US9012506B2 (en) | 2004-09-28 | 2015-04-21 | Atrium Medical Corporation | Cross-linked fatty acid-based biomaterials |
US9000040B2 (en) | 2004-09-28 | 2015-04-07 | Atrium Medical Corporation | Cross-linked fatty acid-based biomaterials |
US9801913B2 (en) | 2004-09-28 | 2017-10-31 | Atrium Medical Corporation | Barrier layer |
US10076641B2 (en) | 2005-05-11 | 2018-09-18 | The Spectranetics Corporation | Methods and systems for delivering substances into luminal walls |
US9427423B2 (en) | 2009-03-10 | 2016-08-30 | Atrium Medical Corporation | Fatty-acid based particles |
US9278161B2 (en) | 2005-09-28 | 2016-03-08 | Atrium Medical Corporation | Tissue-separating fatty acid adhesion barrier |
US20080243068A1 (en) * | 2005-12-29 | 2008-10-02 | Kamal Ramzipoor | Methods and apparatus for treatment of venous insufficiency |
US7919108B2 (en) * | 2006-03-10 | 2011-04-05 | Cook Incorporated | Taxane coatings for implantable medical devices |
DE102006028232A1 (de) * | 2006-06-20 | 2007-12-27 | Bayer Technology Services Gmbh | Vorrichtung und Verfahren zur Berechnung und Bereitstellung einer Medikamentendosis |
US8425459B2 (en) | 2006-11-20 | 2013-04-23 | Lutonix, Inc. | Medical device rapid drug releasing coatings comprising a therapeutic agent and a contrast agent |
US20080276935A1 (en) | 2006-11-20 | 2008-11-13 | Lixiao Wang | Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs |
US8430055B2 (en) | 2008-08-29 | 2013-04-30 | Lutonix, Inc. | Methods and apparatuses for coating balloon catheters |
US9737640B2 (en) | 2006-11-20 | 2017-08-22 | Lutonix, Inc. | Drug releasing coatings for medical devices |
US8414525B2 (en) | 2006-11-20 | 2013-04-09 | Lutonix, Inc. | Drug releasing coatings for medical devices |
US20080175887A1 (en) * | 2006-11-20 | 2008-07-24 | Lixiao Wang | Treatment of Asthma and Chronic Obstructive Pulmonary Disease With Anti-proliferate and Anti-inflammatory Drugs |
US8998846B2 (en) | 2006-11-20 | 2015-04-07 | Lutonix, Inc. | Drug releasing coatings for balloon catheters |
US9700704B2 (en) | 2006-11-20 | 2017-07-11 | Lutonix, Inc. | Drug releasing coatings for balloon catheters |
US8414526B2 (en) | 2006-11-20 | 2013-04-09 | Lutonix, Inc. | Medical device rapid drug releasing coatings comprising oils, fatty acids, and/or lipids |
US8414910B2 (en) | 2006-11-20 | 2013-04-09 | Lutonix, Inc. | Drug releasing coatings for medical devices |
US20080140002A1 (en) * | 2006-12-06 | 2008-06-12 | Kamal Ramzipoor | System for delivery of biologically active substances with actuating three dimensional surface |
US8597720B2 (en) | 2007-01-21 | 2013-12-03 | Hemoteq Ag | Medical product for treating stenosis of body passages and for preventing threatening restenosis |
JP2008305262A (ja) * | 2007-06-08 | 2008-12-18 | Konica Minolta Business Technologies Inc | サーバ及びシンクライアント環境でのプリンタ紹介方法 |
US9192697B2 (en) | 2007-07-03 | 2015-11-24 | Hemoteq Ag | Balloon catheter for treating stenosis of body passages and for preventing threatening restenosis |
DE102007036685A1 (de) | 2007-08-03 | 2009-02-05 | Innora Gmbh | Verbesserte arzneimittelbeschichtete Medizinprodukte deren Herstellung und Verwendung |
DE102007040868A1 (de) | 2007-08-29 | 2009-04-16 | Innora Gmbh | Ballonkatheter mit Schutz vor Auffaltung |
JP5356239B2 (ja) * | 2007-09-28 | 2013-12-04 | テルモ株式会社 | 生体内留置物 |
WO2009065078A1 (en) * | 2007-11-14 | 2009-05-22 | Pathway Medical Technologies, Inc. | Delivery and administration of compositions using interventional catheters |
CN102316922B (zh) | 2007-11-21 | 2015-06-03 | 因瓦泰克有限公司 | 用于将药物布置在血管成形术球囊上的方法 |
DE102008008926A1 (de) * | 2008-02-13 | 2009-08-20 | Biotronik Vi Patent Ag | System zum Einbringen einer intraluminalen Endoprothese und Verfahren zur Herstellung eines derartigen Systems |
DE102008008925A1 (de) * | 2008-02-13 | 2009-08-20 | Biotronik Vi Patent Ag | Katheter, System zum Einbringen einer intraluminalen Endoprothese sowie Verfahren zur Herstellung derselben |
US9126025B2 (en) | 2008-05-01 | 2015-09-08 | Bayer Intellectual Property Gmbh | Method of coating a folded catheter balloon |
DE112009001065A5 (de) | 2008-05-31 | 2011-04-14 | Lothar Sellin | Medizinische Einrichtung und Verfahren zu ihrer Herstellung |
US8128951B2 (en) | 2008-09-15 | 2012-03-06 | Cv Ingenuity Corp. | Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens |
US9198968B2 (en) | 2008-09-15 | 2015-12-01 | The Spectranetics Corporation | Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens |
US8114429B2 (en) | 2008-09-15 | 2012-02-14 | Cv Ingenuity Corp. | Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens |
US8257722B2 (en) | 2008-09-15 | 2012-09-04 | Cv Ingenuity Corp. | Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens |
US8076529B2 (en) | 2008-09-26 | 2011-12-13 | Abbott Cardiovascular Systems, Inc. | Expandable member formed of a fibrous matrix for intraluminal drug delivery |
US8226603B2 (en) | 2008-09-25 | 2012-07-24 | Abbott Cardiovascular Systems Inc. | Expandable member having a covering formed of a fibrous matrix for intraluminal drug delivery |
US8049061B2 (en) | 2008-09-25 | 2011-11-01 | Abbott Cardiovascular Systems, Inc. | Expandable member formed of a fibrous matrix having hydrogel polymer for intraluminal drug delivery |
WO2010080575A2 (en) | 2008-12-18 | 2010-07-15 | Michal Konstantino | Method and apparatus for transport of substances into body tissue |
IT1394522B1 (it) | 2009-01-09 | 2012-07-05 | Invatec Technology Ct Gmbh | Dispositivo medicale con rilascio di farmaco |
US20100261662A1 (en) * | 2009-04-09 | 2010-10-14 | Endologix, Inc. | Utilization of mural thrombus for local drug delivery into vascular tissue |
WO2010120620A1 (en) | 2009-04-13 | 2010-10-21 | Cook Incorporated | Coated balloon catheter |
EP2442917B1 (de) | 2009-06-17 | 2015-11-04 | DOT GmbH | Verfahren und vorrichtung zur beschichtung von kathetern oder ballonkathetern |
ES2550634T3 (es) | 2009-07-10 | 2015-11-11 | Boston Scientific Scimed, Inc. | Uso de nanocristales para un balón de suministro de fármaco |
WO2011008393A2 (en) | 2009-07-17 | 2011-01-20 | Boston Scientific Scimed, Inc. | Nucleation of drug delivery balloons to provide improved crystal size and density |
US20110038910A1 (en) | 2009-08-11 | 2011-02-17 | Atrium Medical Corporation | Anti-infective antimicrobial-containing biomaterials |
EP2452701A4 (en) | 2009-08-27 | 2014-04-23 | Terumo Corp | MEDICAL INSTRUMENT FOR ADMINISTERING A MEDICINE |
US8480620B2 (en) | 2009-12-11 | 2013-07-09 | Abbott Cardiovascular Systems Inc. | Coatings with tunable solubility profile for drug-coated balloon |
US8951595B2 (en) | 2009-12-11 | 2015-02-10 | Abbott Cardiovascular Systems Inc. | Coatings with tunable molecular architecture for drug-coated balloon |
JP2013514278A (ja) | 2009-12-18 | 2013-04-25 | インターフェース バイオロジクス,インコーポレーテッド | 自己集合コーティングからの薬物の局所送達 |
WO2011119536A1 (en) | 2010-03-22 | 2011-09-29 | Abbott Cardiovascular Systems Inc. | Stent delivery system having a fibrous matrix covering with improved stent retention |
EP2380605A1 (en) | 2010-04-19 | 2011-10-26 | InnoRa Gmbh | Improved formulations for drug-coated medical devices |
EP2380604A1 (en) | 2010-04-19 | 2011-10-26 | InnoRa Gmbh | Improved coating formulations for scoring or cutting balloon catheters |
DE102010023105A1 (de) * | 2010-06-04 | 2011-12-08 | Bayer Schering Pharma Aktiengesellschaft | Gadobutrolherstellung im Eintopfverfahren mittels DMF-acetal und N-Methylimidazol |
EP2593141B1 (en) | 2010-07-16 | 2018-07-04 | Atrium Medical Corporation | Composition and methods for altering the rate of hydrolysis of cured oil-based materials |
WO2012031236A1 (en) | 2010-09-02 | 2012-03-08 | Boston Scientific Scimed, Inc. | Coating process for drug delivery balloons using heat-induced rewrap memory |
DE102011000340A1 (de) | 2010-12-04 | 2012-06-06 | Alexander Rübben | Beschichtung und Beschichtungsverfahren für den Ballon eines Ballonkatheters sowie Ballonkatheter mit beschichtetem Ballon |
US20130345629A1 (en) | 2010-12-04 | 2013-12-26 | Alexander Rübben | Coating and coating method for the balloon of a balloon catheter, and balloon catheter with coated balloon |
US9168362B2 (en) | 2010-12-21 | 2015-10-27 | Invatec Technology Center Gmbh | Drug eluting balloon for the treatment of stenosis and method of manufacturing the balloon |
WO2013022458A1 (en) | 2011-08-05 | 2013-02-14 | Boston Scientific Scimed, Inc. | Methods of converting amorphous drug substance into crystalline form |
US9056152B2 (en) | 2011-08-25 | 2015-06-16 | Boston Scientific Scimed, Inc. | Medical device with crystalline drug coating |
WO2013079476A1 (de) | 2011-11-30 | 2013-06-06 | Bayer Materialscience Ag | Arzneimittelbeschichtetes medizinisches gerät und verfahren zu dessen herstellung |
WO2013091722A1 (en) | 2011-12-23 | 2013-06-27 | Innora Gmbh | Drug-coated medical devices |
AU2013238160B2 (en) | 2012-03-27 | 2016-03-31 | Terumo Kabushiki Kaisha | Coating composition and medical device |
WO2013146376A1 (ja) | 2012-03-27 | 2013-10-03 | テルモ株式会社 | コーティング組成物および医療機器 |
ES2574522T3 (es) | 2012-06-08 | 2016-06-20 | Biotronik Ag | Ésteres 40-O-hidrocarburo cíclico de rapamicina, composiciones y procedimientos |
US9867880B2 (en) | 2012-06-13 | 2018-01-16 | Atrium Medical Corporation | Cured oil-hydrogel biomaterial compositions for controlled drug delivery |
US9956385B2 (en) | 2012-06-28 | 2018-05-01 | The Spectranetics Corporation | Post-processing of a medical device to control morphology and mechanical properties |
US10064981B2 (en) | 2012-07-10 | 2018-09-04 | Bayer Pharma Aktiengesellschaft | Catheter with drug coating |
US10881839B2 (en) | 2012-10-26 | 2021-01-05 | Urotronic, Inc. | Drug-coated balloon catheters for body lumens |
CN104936629A (zh) | 2012-10-26 | 2015-09-23 | 优敦力公司 | 用于非血管狭窄的药物涂层球囊导管 |
US10898700B2 (en) | 2012-10-26 | 2021-01-26 | Urotronic, Inc. | Balloon catheters for body lumens |
US10850076B2 (en) | 2012-10-26 | 2020-12-01 | Urotronic, Inc. | Balloon catheters for body lumens |
US10806830B2 (en) | 2012-10-26 | 2020-10-20 | Urotronic, Inc. | Drug-coated balloon catheters for body lumens |
WO2020172560A1 (en) | 2019-02-22 | 2020-08-27 | Urotronic, Inc. | Drug-coated balloon catheters for body lumens |
US11938287B2 (en) | 2012-10-26 | 2024-03-26 | Urotronic, Inc. | Drug-coated balloon catheters for body lumens |
US11504450B2 (en) | 2012-10-26 | 2022-11-22 | Urotronic, Inc. | Drug-coated balloon catheters for body lumens |
DE102013104029A1 (de) | 2013-04-22 | 2014-10-23 | Innora Gmbh | Ballonkatheter |
US20150190618A1 (en) | 2014-01-09 | 2015-07-09 | Medtronic Vascular, Inc. | Balloon Catheter With Elastomeric Sheath and Methods |
US10525171B2 (en) | 2014-01-24 | 2020-01-07 | The Spectranetics Corporation | Coatings for medical devices |
US9655998B2 (en) | 2014-08-07 | 2017-05-23 | Cook Medical Technologies Llc | Encapsulated drug compositions and methods of use thereof |
US9180226B1 (en) | 2014-08-07 | 2015-11-10 | Cook Medical Technologies Llc | Compositions and devices incorporating water-insoluble therapeutic agents and methods of the use thereof |
US11241520B2 (en) | 2014-08-07 | 2022-02-08 | Cook Medical Technologies Llc | Compositions and devices incorporating water-insoluble therapeutic agents and methods of the use thereof |
US9675734B2 (en) | 2014-08-29 | 2017-06-13 | Invatec S.P.A. | Medical balloon coated with therapeutic agent, carboxylic acid, and salt thereof |
US11904072B2 (en) | 2015-04-24 | 2024-02-20 | Urotronic, Inc. | Drug coated balloon catheters for nonvascular strictures |
CN118320191A (zh) | 2015-04-24 | 2024-07-12 | 优敦力公司 | 用于非血管狭窄的药物涂布的球囊导管 |
TWI586391B (zh) * | 2016-06-23 | 2017-06-11 | 何中庸 | 一種氣囊管裝置與運作方法 |
CN108543165B (zh) * | 2018-02-27 | 2021-06-18 | 宁波胜杰康生物科技有限公司 | 一种基于载体的肌功能辅助装置 |
WO2019222843A1 (en) | 2018-05-22 | 2019-11-28 | Interface Biologics, Inc. | Compositions and methods for delivering drugs to a vessel wall |
Family Cites Families (315)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US554181A (en) * | 1896-02-04 | Robert frederick hall | ||
US2624642A (en) * | 1950-05-24 | 1953-01-06 | Symington Gould Corp | Journal box lid |
US4101984A (en) | 1975-05-09 | 1978-07-25 | Macgregor David C | Cardiovascular prosthetic devices and implants with porous systems |
US4247352A (en) * | 1976-11-29 | 1981-01-27 | North American Philips Corporation | Method of bonding crystal layers to insulating substrates |
DE2721752C2 (de) | 1977-05-13 | 1983-12-29 | Siemens AG, 1000 Berlin und 8000 München | In einen menschlichen oder tierischen Körper implantierbares Gerät zur Infusion einer medizinischen Flüssigkeit |
DE2909439A1 (de) * | 1979-03-08 | 1980-09-18 | Schering Ag | Neue nichtionische roentgenkontrastmittel |
US4479795A (en) | 1979-06-29 | 1984-10-30 | The Procter & Gamble Company | Antimicrobial polymer compositions |
US4343788A (en) | 1979-06-29 | 1982-08-10 | The Procter & Gamble Company | Antimicrobial polymer compositions |
US4305926A (en) | 1979-09-13 | 1981-12-15 | Johannes Everse | Immobilization of Streptokinase |
JPS57500588A (pt) | 1980-03-27 | 1982-04-08 | ||
JPS5881601A (ja) * | 1981-11-11 | 1983-05-17 | 毛利 正巳 | ずれ落ちないガ−タ付靴下 |
US4502159A (en) | 1982-08-12 | 1985-03-05 | Shiley Incorporated | Tubular prostheses prepared from pericardial tissue |
US4769013A (en) | 1982-09-13 | 1988-09-06 | Hydromer, Inc. | Bio-effecting medical material and device |
FR2540128B1 (fr) | 1983-01-27 | 1986-02-21 | Rhone Poulenc Spec Chim | Compositions organopolysiloxaniques contenant des polyacyloxysilanes et durcissant tres rapidement en elastomeres en presence d'accelerateur du type hydroxyde metallique |
US4573476A (en) * | 1983-11-14 | 1986-03-04 | Ruiz Oscar F | Angiographic catheter |
US5108424A (en) | 1984-01-30 | 1992-04-28 | Meadox Medicals, Inc. | Collagen-impregnated dacron graft |
US5197977A (en) | 1984-01-30 | 1993-03-30 | Meadox Medicals, Inc. | Drug delivery collagen-impregnated synthetic vascular graft |
US5456663A (en) | 1984-05-25 | 1995-10-10 | Lemelson; Jerome H. | Drugs and methods for treating diseases |
US4879135A (en) | 1984-07-23 | 1989-11-07 | University Of Medicine And Dentistry Of New Jersey | Drug bonded prosthesis and process for producing same |
GB8422876D0 (en) | 1984-09-11 | 1984-10-17 | Secr Defence | Silicon implant devices |
US4677143A (en) | 1984-10-01 | 1987-06-30 | Baxter Travenol Laboratories, Inc. | Antimicrobial compositions |
US4677413A (en) * | 1984-11-20 | 1987-06-30 | Vishay Intertechnology, Inc. | Precision power resistor with very low temperature coefficient of resistance |
WO1986007541A1 (en) | 1985-06-19 | 1986-12-31 | Yasushi Zyo | Composition which can impart antithrombotic ability and medical apparatus to be in contact with blood |
JPH0663145B2 (ja) | 1985-09-11 | 1994-08-17 | 豊和工業株式会社 | 紡機におけるスライバ−供給方法および装置 |
US4733665C2 (en) | 1985-11-07 | 2002-01-29 | Expandable Grafts Partnership | Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft |
US4917686A (en) | 1985-12-16 | 1990-04-17 | Colorado Biomedical, Inc. | Antimicrobial device and method |
US6051405A (en) | 1986-09-24 | 2000-04-18 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Constructs encoding recombinant antibody-toxin fusion proteins |
US5059211A (en) * | 1987-06-25 | 1991-10-22 | Duke University | Absorbable vascular stent |
US4909799A (en) | 1987-09-18 | 1990-03-20 | Olav Thulesius | Methods for preventing thrombosis; and surgical implant having reduced platelet deposition characteristics |
US5098977A (en) | 1987-09-23 | 1992-03-24 | Board Of Regents, The University Of Texas System | Methods and compositions for providing articles having improved biocompatability characteristics |
US4886062A (en) | 1987-10-19 | 1989-12-12 | Medtronic, Inc. | Intravascular radially expandable stent and method of implant |
US5019601A (en) | 1987-12-29 | 1991-05-28 | Cuno, Incorporated | Elastomeric composition containing therapeutic agents and articles manufactured therefrom |
JP2561853B2 (ja) | 1988-01-28 | 1996-12-11 | 株式会社ジェイ・エム・エス | 形状記憶性を有する成形体及びその使用方法 |
US5019096A (en) | 1988-02-11 | 1991-05-28 | Trustees Of Columbia University In The City Of New York | Infection-resistant compositions, medical devices and surfaces and methods for preparing and using same |
US5157049A (en) | 1988-03-07 | 1992-10-20 | The United States Of America As Represented By The Department Of Health & Human Services | Method of treating cancers sensitive to treatment with water soluble derivatives of taxol |
US4950256A (en) | 1988-04-07 | 1990-08-21 | Luther Medical Products, Inc. | Non-thrombogenic intravascular time release catheter |
US4994047A (en) | 1988-05-06 | 1991-02-19 | Menlo Care, Inc. | Multi-layer cannula structure |
US5770198A (en) | 1988-05-18 | 1998-06-23 | The Research Foundation Of The State Of New York | Platelet-specific chimeric 7E3 immunoglobulin |
US5182317A (en) | 1988-06-08 | 1993-01-26 | Cardiopulmonics, Inc. | Multifunctional thrombo-resistant coatings and methods of manufacture |
US5019393A (en) | 1988-08-03 | 1991-05-28 | New England Deaconess Hospital Corporation | Biocompatible substance with thromboresistance |
US5019090A (en) | 1988-09-01 | 1991-05-28 | Corvita Corporation | Radially expandable endoprosthesis and the like |
US5053048A (en) | 1988-09-22 | 1991-10-01 | Cordis Corporation | Thromboresistant coating |
US5298255A (en) | 1988-10-28 | 1994-03-29 | Terumo Kabushiki Kaisha | Antithrombic medical material, artificial internal organ, and method for production of antithrombic medical material |
US4925668A (en) | 1989-01-18 | 1990-05-15 | Becton, Dickinson And Company | Anti-infective and lubricious medical articles and method for their preparation |
US5165952A (en) | 1989-01-18 | 1992-11-24 | Becton, Dickinson And Company | Anti-infective and antithrombogenic medical articles and method for their preparation |
US6146358A (en) | 1989-03-14 | 2000-11-14 | Cordis Corporation | Method and apparatus for delivery of therapeutic agent |
US5004461A (en) | 1989-03-23 | 1991-04-02 | Wilson Joseph E | Methods for rendering plastics thromboresistant and product |
WO1990013293A1 (en) | 1989-04-28 | 1990-11-15 | Syracuse University | Cytochalasin compositions and therapeutic methods |
US5051257A (en) | 1989-05-09 | 1991-09-24 | Pietronigro Dennis D | Antineoplastic solution and method for treating neoplasms |
WO1990013332A1 (en) | 1989-05-11 | 1990-11-15 | Cedars-Sinai Medical Center | Stent with sustained drug delivery |
US4997643A (en) * | 1989-07-12 | 1991-03-05 | Union Carbide Chemicals And Plastics Company Inc. | Polymeric salt delivery systems |
US5232685A (en) * | 1989-11-03 | 1993-08-03 | Schering Aktiengesellschaft | Nonionic x-ray contrast medium with high iodine content |
US5067491A (en) | 1989-12-08 | 1991-11-26 | Becton, Dickinson And Company | Barrier coating on blood contacting devices |
US5059166A (en) | 1989-12-11 | 1991-10-22 | Medical Innovative Technologies R & D Limited Partnership | Intra-arterial stent with the capability to inhibit intimal hyperplasia |
US5304121A (en) | 1990-12-28 | 1994-04-19 | Boston Scientific Corporation | Drug delivery system making use of a hydrogel polymer coating |
US5674192A (en) | 1990-12-28 | 1997-10-07 | Boston Scientific Corporation | Drug delivery |
US5135516A (en) | 1989-12-15 | 1992-08-04 | Boston Scientific Corporation | Lubricious antithrombogenic catheters, guidewires and coatings |
DE69108423T2 (de) | 1990-02-08 | 1995-07-27 | Howmedica | Aufblasbarer Dilatator. |
DE69110787T2 (de) | 1990-02-28 | 1996-04-04 | Medtronic, Inc., Minneapolis, Minn. | Intraluminale prothese mit wirkstoffeluierung. |
WO1991017724A1 (en) | 1990-05-17 | 1991-11-28 | Harbor Medical Devices, Inc. | Medical device polymer |
US5166143A (en) * | 1990-05-31 | 1992-11-24 | E. R. Squibb & Sons, Inc. | Method for preventing onset of restenosis after angioplasty employing an ace inhibitor |
US5407683A (en) * | 1990-06-01 | 1995-04-18 | Research Corporation Technologies, Inc. | Pharmaceutical solutions and emulsions containing taxol |
US5320634A (en) | 1990-07-03 | 1994-06-14 | Interventional Technologies, Inc. | Balloon catheter with seated cutting edges |
US5112457A (en) | 1990-07-23 | 1992-05-12 | Case Western Reserve University | Process for producing hydroxylated plasma-polymerized films and the use of the films for enhancing the compatiblity of biomedical implants |
US5455040A (en) | 1990-07-26 | 1995-10-03 | Case Western Reserve University | Anticoagulant plasma polymer-modified substrate |
US5163952A (en) | 1990-09-14 | 1992-11-17 | Michael Froix | Expandable polymeric stent with memory and delivery apparatus and method |
US5222971A (en) | 1990-10-09 | 1993-06-29 | Scimed Life Systems, Inc. | Temporary stent and methods for use and manufacture |
US5244654A (en) | 1990-11-08 | 1993-09-14 | Cordis Corporation | Radiofrequency plasma biocompatibility treatment of inside surfaces of medical tubing and the like |
US6524274B1 (en) | 1990-12-28 | 2003-02-25 | Scimed Life Systems, Inc. | Triggered release hydrogel drug delivery system |
JP3372950B2 (ja) | 1990-12-28 | 2003-02-04 | ボストン サイエンティフィック コーポレーション | ドラッグデリバリーシステム |
US5324261A (en) | 1991-01-04 | 1994-06-28 | Medtronic, Inc. | Drug delivery balloon catheter with line of weakness |
US5102402A (en) | 1991-01-04 | 1992-04-07 | Medtronic, Inc. | Releasable coatings on balloon catheters |
US5893840A (en) * | 1991-01-04 | 1999-04-13 | Medtronic, Inc. | Releasable microcapsules on balloon catheters |
US5762638A (en) | 1991-02-27 | 1998-06-09 | Shikani; Alain H. | Anti-infective and anti-inflammatory releasing systems for medical devices |
US5344411A (en) | 1991-02-27 | 1994-09-06 | Leonard Bloom | Method and device for inhibiting HIV, hepatitis B and other viruses and germs when using a catheter in a medical environment |
US5171217A (en) | 1991-02-28 | 1992-12-15 | Indiana University Foundation | Method for delivery of smooth muscle cell inhibitors |
DE4115950A1 (de) | 1991-05-16 | 1992-11-19 | Herberts Gmbh | Fluessige gemische von photoinitiatoren, verfahren zu deren herstellung und deren verwendung |
NL9101159A (nl) | 1991-07-03 | 1993-02-01 | Industrial Res Bv | Vormvast te maken uitzetbare ring, cylinder of huls. |
US5356433A (en) | 1991-08-13 | 1994-10-18 | Cordis Corporation | Biocompatible metal surfaces |
SE9102778D0 (sv) | 1991-09-25 | 1991-09-25 | Siemens Elema Ab | Implanterbar medicinsk anordning |
US6515009B1 (en) | 1991-09-27 | 2003-02-04 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US5464450A (en) | 1991-10-04 | 1995-11-07 | Scimed Lifesystems Inc. | Biodegradable drug delivery vascular stent |
US5500013A (en) | 1991-10-04 | 1996-03-19 | Scimed Life Systems, Inc. | Biodegradable drug delivery vascular stent |
WO1993006792A1 (en) | 1991-10-04 | 1993-04-15 | Scimed Life Systems, Inc. | Biodegradable drug delivery vascular stent |
DE4135193C1 (pt) | 1991-10-22 | 1993-03-11 | Schering Ag Berlin Und Bergkamen, 1000 Berlin, De | |
JP3093375B2 (ja) | 1991-11-01 | 2000-10-03 | 株式会社東海メディカルプロダクツ | 抗血栓性物質の固定化方法 |
US5264220A (en) | 1991-11-12 | 1993-11-23 | Long David M Jr | Method of extending the vascular dwell-time of particulate therapeutic and particulate diagnostic agents |
US5302397A (en) | 1991-11-19 | 1994-04-12 | Amsden Brian G | Polymer-based drug delivery system |
US5270047A (en) | 1991-11-21 | 1993-12-14 | Kauffman Raymond F | Local delivery of dipyridamole for the treatment of proliferative diseases |
EP0643706A1 (en) | 1991-11-27 | 1995-03-22 | Zynaxis Inc. | Compounds, compositions and methods for binding bio-affecting substances to surface membranes of bio-particles |
JPH07502274A (ja) | 1991-12-10 | 1995-03-09 | ラシユ−プレスビタリアン−セントルークス・メデイカル・センター | 多薬剤耐性を低下させる方法および組成物 |
CA2086642C (en) | 1992-01-09 | 2004-06-15 | Randall E. Morris | Method of treating hyperproliferative vascular disease |
US5176626A (en) * | 1992-01-15 | 1993-01-05 | Wilson-Cook Medical, Inc. | Indwelling stent |
US5605896A (en) * | 1992-02-25 | 1997-02-25 | Recordati S.A., Chemical And Pharmaceutical Company | Bicyclic heterocyclic derivatives having α1 adrenergic and 5HT1A activities |
US5217493A (en) | 1992-03-11 | 1993-06-08 | Board Of Regents, The University Of Texas System | Antibacterial coated medical implants |
US5599352A (en) | 1992-03-19 | 1997-02-04 | Medtronic, Inc. | Method of making a drug eluting stent |
US5282823A (en) | 1992-03-19 | 1994-02-01 | Medtronic, Inc. | Intravascular radially expandable stent |
US5571166A (en) * | 1992-03-19 | 1996-11-05 | Medtronic, Inc. | Method of making an intraluminal stent |
US5288711A (en) | 1992-04-28 | 1994-02-22 | American Home Products Corporation | Method of treating hyperproliferative vascular disease |
US5383927A (en) | 1992-05-07 | 1995-01-24 | Intervascular Inc. | Non-thromogenic vascular prosthesis |
US5629008A (en) | 1992-06-02 | 1997-05-13 | C.R. Bard, Inc. | Method and device for long-term delivery of drugs |
US5383928A (en) | 1992-06-10 | 1995-01-24 | Emory University | Stent sheath for local drug delivery |
DE4222380A1 (de) | 1992-07-08 | 1994-01-13 | Ernst Peter Prof Dr M Strecker | In den Körper eines Patienten perkutan implantierbare Endoprothese |
DE4225553C1 (de) | 1992-08-03 | 1994-05-11 | Michael Dr Rudolf | Ballonkatheter |
EP0752885B1 (en) | 1992-09-25 | 2003-07-09 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US5336178A (en) | 1992-11-02 | 1994-08-09 | Localmed, Inc. | Intravascular catheter with infusion array |
US5449382A (en) | 1992-11-04 | 1995-09-12 | Dayton; Michael P. | Minimally invasive bioactivated endoprosthesis for vessel repair |
US5578075B1 (en) | 1992-11-04 | 2000-02-08 | Daynke Res Inc | Minimally invasive bioactivated endoprosthesis for vessel repair |
NZ258044A (en) * | 1992-11-27 | 1995-12-21 | Faulding F H & Co Ltd | Pharmaceutical composition comprising taxol, solubilising agent, an acid and an organic solvent |
US5342348A (en) | 1992-12-04 | 1994-08-30 | Kaplan Aaron V | Method and device for treating and enlarging body lumens |
EP0604022A1 (en) | 1992-12-22 | 1994-06-29 | Advanced Cardiovascular Systems, Inc. | Multilayered biodegradable stent and method for its manufacture |
US5443458A (en) | 1992-12-22 | 1995-08-22 | Advanced Cardiovascular Systems, Inc. | Multilayered biodegradable stent and method of manufacture |
US5419760A (en) | 1993-01-08 | 1995-05-30 | Pdt Systems, Inc. | Medicament dispensing stent for prevention of restenosis of a blood vessel |
US5229172A (en) | 1993-01-19 | 1993-07-20 | Medtronic, Inc. | Modification of polymeric surface by graft polymerization |
US5981568A (en) | 1993-01-28 | 1999-11-09 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
ATE485825T1 (de) | 1993-01-28 | 2010-11-15 | Boston Scient Ltd | Therapeutische inhibitoren der zellen der glatten gefässmuskulatur |
US6491938B2 (en) | 1993-05-13 | 2002-12-10 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US5916596A (en) | 1993-02-22 | 1999-06-29 | Vivorx Pharmaceuticals, Inc. | Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
US5976534A (en) * | 1993-02-25 | 1999-11-02 | Zymogenetics, Inc. | Inhibition of intimal hyperplasia using antibodies to PDGF receptors and heparin |
US5534288A (en) | 1993-03-23 | 1996-07-09 | United States Surgical Corporation | Infection-resistant surgical devices and methods of making them |
US5607463A (en) | 1993-03-30 | 1997-03-04 | Medtronic, Inc. | Intravascular medical device |
WO1994023787A1 (en) | 1993-04-22 | 1994-10-27 | Rammler David H | Sampling balloon catheter |
US5464650A (en) | 1993-04-26 | 1995-11-07 | Medtronic, Inc. | Intravascular stent and method |
SE9301422D0 (sv) | 1993-04-28 | 1993-04-28 | Kabi Pharmacia Ab | Method and means for inhibiting posterior capsule opacification |
US5531715A (en) | 1993-05-12 | 1996-07-02 | Target Therapeutics, Inc. | Lubricious catheters |
DE69435120D1 (de) | 1993-05-13 | 2008-09-04 | Poniard Pharmaceuticals Inc | Ein Inhibitor für glatte Gefässmuskelzellen für therapeutische Nutzung |
US20030203976A1 (en) | 1993-07-19 | 2003-10-30 | William L. Hunter | Anti-angiogenic compositions and methods of use |
ATE339975T1 (de) | 1993-07-19 | 2006-10-15 | Angiotech Pharm Inc | Anti-angiogener stent und verfahren zu dessen herstellung |
US5716981A (en) * | 1993-07-19 | 1998-02-10 | Angiogenesis Technologies, Inc. | Anti-angiogenic compositions and methods of use |
DE69434598T3 (de) | 1993-07-29 | 2010-07-29 | The United States Of America Represented By The Secretary, Department Of Health And Human Services | Verwendung von Paclitaxel und seinen Derivaten zur Herstellung eines Medikaments für die Behandlung von Restenose |
US5567495A (en) | 1993-08-06 | 1996-10-22 | The Trustees Of Columbia University In The City Of New York | Infection resistant medical devices |
US5746745A (en) | 1993-08-23 | 1998-05-05 | Boston Scientific Corporation | Balloon catheter |
EP0746362B1 (en) | 1993-08-23 | 2002-01-16 | Boston Scientific Corporation | Improved balloon catheter |
US5380299A (en) | 1993-08-30 | 1995-01-10 | Med Institute, Inc. | Thrombolytic treated intravascular medical device |
US5531716A (en) | 1993-09-29 | 1996-07-02 | Hercules Incorporated | Medical devices subject to triggered disintegration |
TW406020B (en) | 1993-09-29 | 2000-09-21 | Bristol Myers Squibb Co | Stabilized pharmaceutical composition and its method for preparation and stabilizing solvent |
DE4334272C2 (de) | 1993-10-07 | 1996-07-18 | Stemberger Axel Dr | Beschichtung für Biomaterial und seine Verwendung |
US5457113A (en) | 1993-10-15 | 1995-10-10 | Eli Lilly And Company | Methods for inhibiting vascular smooth muscle cell proliferation and restinosis |
US5454886A (en) | 1993-11-18 | 1995-10-03 | Westaim Technologies Inc. | Process of activating anti-microbial materials |
ATE354377T1 (de) | 1993-12-02 | 2007-03-15 | Max Delbrueck Centrum | Antitumormittel, enthaltend ein zytostatikum und ein kontrastmittel |
DE4341478C2 (de) | 1993-12-02 | 1998-10-08 | Max Delbrueck Centrum | Mittel zur Antitumortherapie |
US5397307A (en) | 1993-12-07 | 1995-03-14 | Schneider (Usa) Inc. | Drug delivery PTCA catheter and method for drug delivery |
CA2180556C (en) | 1994-01-26 | 2007-08-07 | Mark A. Reiley | Improved inflatable device for use in surgical protocol relating to fixation of bone |
DE4408768C1 (de) * | 1994-03-15 | 1995-05-04 | Siemens Ag | Verfahren zur Filterung einer digitalen Wertefolge mit verbessertem Rauschverhalten und Schaltungsanordnung zur Durchführung des Verfahrens |
US5510330A (en) | 1994-03-25 | 1996-04-23 | Boehringer Mannheim Gmbh | Combinations of thrombolytically active proteins and non-heparin anticoagulants, and uses thereof. |
DE4412055C1 (de) | 1994-04-07 | 1995-05-18 | Siemens Ag | CMOS-Abschlußwiderstandsschaltung |
US5554181A (en) | 1994-05-04 | 1996-09-10 | Regents Of The University Of Minnesota | Stent |
JP3631777B2 (ja) | 1994-06-03 | 2005-03-23 | テルモ株式会社 | 薬剤投与カテーテル |
US5824644A (en) * | 1994-07-07 | 1998-10-20 | G. D. Searle & Co. | Method of attenuating arterial stenosis |
US6123715A (en) * | 1994-07-08 | 2000-09-26 | Amplatz; Curtis | Method of forming medical devices; intravascular occlusion devices |
US5649977A (en) | 1994-09-22 | 1997-07-22 | Advanced Cardiovascular Systems, Inc. | Metal reinforced polymer stent |
ATE434423T1 (de) | 1994-10-17 | 2009-07-15 | Igaki Iryo Sekkei Kk | Medikamentenfreisetzender stent |
US5643580A (en) * | 1994-10-17 | 1997-07-01 | Surface Genesis, Inc. | Biocompatible coating, medical device using the same and methods |
GB9423419D0 (en) * | 1994-11-19 | 1995-01-11 | Andaris Ltd | Preparation of hollow microcapsules |
US5626562A (en) | 1994-11-28 | 1997-05-06 | Devices For Vascular Intervention | Drug delivery catheter |
DE4446694A1 (de) | 1994-12-09 | 1996-06-13 | Schering Ag | Verwendung von Zusätzen zu Kontrastmitteln zur Verbesserung der Bildgebung |
CA2163837C (en) | 1994-12-13 | 1999-07-20 | Robert K. Perrone | Crystalline paclitaxel hydrates |
US5599576A (en) | 1995-02-06 | 1997-02-04 | Surface Solutions Laboratories, Inc. | Medical apparatus with scratch-resistant coating and method of making same |
DE19505155A1 (de) | 1995-02-16 | 1996-08-22 | Magna Zippex Autotechnik Gmbh | Verfahren zum Herstellen eines Auskleidungsteiles aus Kunststoff und ein insbesonders nach diesem Verfahren hergestelltes Auskleidungsteil |
US6558798B2 (en) * | 1995-02-22 | 2003-05-06 | Scimed Life Systems, Inc. | Hydrophilic coating and substrates coated therewith having enhanced durability and lubricity |
US5681846A (en) | 1995-03-17 | 1997-10-28 | Board Of Regents, The University Of Texas System | Extended stability formulations for paclitaxel |
US5605696A (en) | 1995-03-30 | 1997-02-25 | Advanced Cardiovascular Systems, Inc. | Drug loaded polymeric material and method of manufacture |
DE19514104C2 (de) | 1995-04-13 | 1997-05-28 | Behringwerke Ag | Beschichtung für in den Blutstrom oder in das Gewebe des menschlichen Körpers einbringbares Biomaterial |
US5624704A (en) | 1995-04-24 | 1997-04-29 | Baylor College Of Medicine | Antimicrobial impregnated catheters and other medical implants and method for impregnating catheters and other medical implants with an antimicrobial agent |
IL113926A (en) | 1995-05-31 | 2000-06-01 | Korenstein Rafi | Contrast medium with improved patient's tolerance thereto and its use |
US5820607A (en) | 1995-06-05 | 1998-10-13 | Board Of Regents, University Of Texas Systems | Multipurpose anti-microbial silastic sheath system for the prevention of device-related infections |
US7611533B2 (en) | 1995-06-07 | 2009-11-03 | Cook Incorporated | Coated implantable medical device |
US5772640A (en) | 1996-01-05 | 1998-06-30 | The Trustees Of Columbia University Of The City Of New York | Triclosan-containing medical devices |
US6774278B1 (en) | 1995-06-07 | 2004-08-10 | Cook Incorporated | Coated implantable medical device |
US7550005B2 (en) | 1995-06-07 | 2009-06-23 | Cook Incorporated | Coated implantable medical device |
US5609629A (en) | 1995-06-07 | 1997-03-11 | Med Institute, Inc. | Coated implantable medical device |
AU716005B2 (en) | 1995-06-07 | 2000-02-17 | Cook Medical Technologies Llc | Implantable medical device |
EP0804151B1 (en) | 1995-06-29 | 2002-09-11 | Macrochem Corporation | Lipophilic and amphiphilic film-forming polymer compositions, and use thereof in topical agents delivery system and method of delivering agents to the skin |
US5607475A (en) | 1995-08-22 | 1997-03-04 | Medtronic, Inc. | Biocompatible medical article and method |
EP0861104B1 (en) | 1995-11-08 | 2000-12-27 | SciMed Life Systems, Inc. | Method of balloon formation by cold drawing/necking |
US5792158A (en) | 1995-11-15 | 1998-08-11 | Lary; Banning Gray | University dilator with expandable incisor |
CZ234898A3 (cs) | 1996-01-25 | 1998-11-11 | Schering Aktiengesellschaft | Zdokonalené koncentrované injekční a infusní roztoky pro intravazální použití |
US6264642B1 (en) | 1996-02-29 | 2001-07-24 | Kimberly-Clark Worldwide, Inc. | Elasticized laminate, liquid impermeable backsheet for a disposable absorbent article |
US6441025B2 (en) * | 1996-03-12 | 2002-08-27 | Pg-Txl Company, L.P. | Water soluble paclitaxel derivatives |
PL189698B1 (pl) * | 1996-03-12 | 2005-09-30 | Pg Txl Co | Kompozycja farmaceutyczna zawierająca lek przeciwnowotworowy i jej zastosowania |
US6071285A (en) | 1996-03-25 | 2000-06-06 | Lashinski; Robert D. | Rapid exchange folded balloon catheter and stent delivery system |
AU2821597A (en) | 1996-05-03 | 1997-11-26 | Emed Corporation | Combined coronary stent deployment and local delivery of an agent |
EP0906129B1 (en) | 1996-06-04 | 2002-08-28 | Cook Incorporated | Implantable medical device |
US20040068241A1 (en) | 1996-06-04 | 2004-04-08 | Fischer Frank J. | Implantable medical device |
EP0820784B1 (en) | 1996-07-24 | 2003-06-11 | Cordis Corporation | Balloon catheter and methods of use |
US5797887A (en) * | 1996-08-27 | 1998-08-25 | Novovasc Llc | Medical device with a surface adapted for exposure to a blood stream which is coated with a polymer containing a nitrosyl-containing organo-metallic compound which releases nitric oxide from the coating to mediate platelet aggregation |
CA2209366C (en) | 1996-09-13 | 2004-11-02 | Interventional Technologies, Inc. | Incisor-dilator with tapered balloon |
US5954740A (en) | 1996-09-23 | 1999-09-21 | Boston Scientific Corporation | Catheter balloon having raised radial segments |
US5978698A (en) * | 1996-10-08 | 1999-11-02 | Merck & Co., Inc. | Angioplasty procedure using nonionic contrast media |
IT1294967B1 (it) | 1996-10-09 | 1999-04-23 | Ist Farmacoterapico It Spa | Composizione immunogenica da tlp |
PL332820A1 (en) * | 1996-10-21 | 1999-10-11 | Nycomed Imaging As | Improved contrast media |
US5893867A (en) | 1996-11-06 | 1999-04-13 | Percusurge, Inc. | Stent positioning apparatus and method |
US6495579B1 (en) | 1996-12-02 | 2002-12-17 | Angiotech Pharmaceuticals, Inc. | Method for treating multiple sclerosis |
US6515016B2 (en) | 1996-12-02 | 2003-02-04 | Angiotech Pharmaceuticals, Inc. | Composition and methods of paclitaxel for treating psoriasis |
US6071616A (en) | 1996-12-05 | 2000-06-06 | Texas Instruments Incorporated | Opaque low reflecting coating aperture on glass |
US5980972A (en) | 1996-12-20 | 1999-11-09 | Schneider (Usa) Inc | Method of applying drug-release coatings |
US5871692A (en) | 1997-01-14 | 1999-02-16 | Steris Corporation | Method and apparatus for cleaning, decontaminating, and sterilizing catheters |
US5868719A (en) | 1997-01-15 | 1999-02-09 | Boston Scientific Corporation | Drug delivery balloon catheter device |
US6491619B1 (en) | 1997-01-31 | 2002-12-10 | Endologix, Inc | Radiation delivery catheters and dosimetry methods |
WO1998036784A1 (en) | 1997-02-20 | 1998-08-27 | Cook Incorporated | Coated implantable medical device |
EP0975340B2 (en) | 1997-03-31 | 2009-10-28 | Boston Scientific Limited | Therapeutic inhibitor of vascular smooth muscle cells |
US6240616B1 (en) | 1997-04-15 | 2001-06-05 | Advanced Cardiovascular Systems, Inc. | Method of manufacturing a medicated porous metal prosthesis |
US6273913B1 (en) | 1997-04-18 | 2001-08-14 | Cordis Corporation | Modified stent useful for delivery of drugs along stent strut |
GB9708240D0 (en) | 1997-04-23 | 1997-06-11 | Nycomed Imaging As | Improvements in or relating to contrast agents |
DE19718339A1 (de) * | 1997-04-30 | 1998-11-12 | Schering Ag | Polymer beschichtete Stents, Verfahren zu ihrer Herstellung und ihre Verwendung zur Restenoseprophylaxe |
US6221467B1 (en) * | 1997-06-03 | 2001-04-24 | Scimed Life Systems, Inc. | Coating gradient for lubricious coatings on balloon catheters |
DE19724796A1 (de) | 1997-06-06 | 1998-12-10 | Max Delbrueck Centrum | Mittel zur Antitumortherapie |
JPH1112160A (ja) | 1997-06-19 | 1999-01-19 | Nippon Schering Kk | 水溶性抗腫瘍薬含有エマルジョン型製剤およびキット |
US6171232B1 (en) | 1997-06-26 | 2001-01-09 | Cordis Corporation | Method for targeting in vivo nitric oxide release |
US6214333B1 (en) | 1997-07-08 | 2001-04-10 | Texas Heart Institute | Vasoprotective recombinant adenovirus vector containing a human TFPI gene |
US6306166B1 (en) | 1997-08-13 | 2001-10-23 | Scimed Life Systems, Inc. | Loading and release of water-insoluble drugs |
CA2298543A1 (en) | 1997-08-13 | 1999-02-25 | James Barry | Loading and release of water-insoluble drugs |
US6248100B1 (en) * | 1997-08-14 | 2001-06-19 | Scimed Life Systems, Inc. | Drainage catheter delivery system |
US5921952A (en) * | 1997-08-14 | 1999-07-13 | Boston Scientific Corporation | Drainage catheter delivery system |
WO1999009729A1 (en) | 1997-08-20 | 1999-02-25 | Maxon Systems Inc. (London) Ltd. | Communication apparatus and method for locating stored entries in an electronic telephone directory |
WO1999012577A1 (en) | 1997-09-05 | 1999-03-18 | Nycomed Imaging As | Polymer particles made of polyvinyl alcohol and comprising a contrast agent for chemoembolization |
US6284333B1 (en) | 1997-09-10 | 2001-09-04 | Scimed Life Systems, Inc. | Medical devices made from polymer blends containing low melting temperature liquid crystal polymers |
US5917772A (en) * | 1997-09-16 | 1999-06-29 | Micron Technology, Inc. | Data input circuit for eliminating idle cycles in a memory device |
WO1999013916A2 (en) | 1997-09-18 | 1999-03-25 | Nycomed Imaging As | Methods and compositions for medical imaging |
US6890546B2 (en) | 1998-09-24 | 2005-05-10 | Abbott Laboratories | Medical devices containing rapamycin analogs |
US7445792B2 (en) | 2003-03-10 | 2008-11-04 | Abbott Laboratories | Medical device having a hydration inhibitor |
US6309420B1 (en) * | 1997-10-14 | 2001-10-30 | Parallax Medical, Inc. | Enhanced visibility materials for implantation in hard tissue |
CA2307314C (en) * | 1997-10-15 | 2008-06-10 | Tyco Group S.A.R.L. | Lubricious coating |
US6273908B1 (en) | 1997-10-24 | 2001-08-14 | Robert Ndondo-Lay | Stents |
US7419683B2 (en) | 1997-10-31 | 2008-09-02 | United States Of America As Represented By The Secretary Of The Army | Method of inhibiting side effects of pharmaceutical compositions containing amphiphilic vehicles or drug carrier molecules |
JP2001522880A (ja) | 1997-11-17 | 2001-11-20 | リポジェニックス・インコーポレイテッド | トコトリエノールを用いて再狭窄を予防する方法 |
US6485514B1 (en) | 1997-12-12 | 2002-11-26 | Supergen, Inc. | Local delivery of therapeutic agents |
US6123923A (en) * | 1997-12-18 | 2000-09-26 | Imarx Pharmaceutical Corp. | Optoacoustic contrast agents and methods for their use |
US6203487B1 (en) | 1997-12-31 | 2001-03-20 | Thomas Jefferson University | Use of magnetic particles in the focal delivery of cells |
CN1224622A (zh) | 1998-01-24 | 1999-08-04 | 张尚权 | 肿瘤靶向造影剂 |
US6221425B1 (en) | 1998-01-30 | 2001-04-24 | Advanced Cardiovascular Systems, Inc. | Lubricious hydrophilic coating for an intracorporeal medical device |
GB9802745D0 (en) * | 1998-02-09 | 1998-04-08 | Pharmacia & Upjohn Spa | Benzyloxy prodigiosine compounds |
US6623521B2 (en) * | 1998-02-17 | 2003-09-23 | Md3, Inc. | Expandable stent with sliding and locking radial elements |
US5997162A (en) | 1998-03-13 | 1999-12-07 | Osram Sylvania Inc. | Horizontal HID vehicle headlamp with magnetic deflection |
US6306151B1 (en) | 1998-03-31 | 2001-10-23 | Interventional Technologies Inc. | Balloon with reciprocating stent incisor |
US6364856B1 (en) | 1998-04-14 | 2002-04-02 | Boston Scientific Corporation | Medical device with sponge coating for controlled drug release |
US6296655B1 (en) | 1998-04-27 | 2001-10-02 | Advanced Cardiovascular Systems, Inc. | Catheter balloon with biased multiple wings |
DE69901927T2 (de) | 1998-04-27 | 2002-10-10 | Surmodics, Inc. | Bioaktive wirkstoffe freisetzende beschichtungen |
WO1999058120A1 (en) * | 1998-05-08 | 1999-11-18 | Rolf Berge | USE OF NON-β-OXIDIZABLE FATTY ACID ANALOGUES FOR TREATMENT OF SYNDROME-X CONDITIONS |
EP1077686B1 (en) | 1998-05-15 | 2008-08-06 | NASA/Johnson Space Center | Externally triggered microcapsules |
WO2000000238A1 (en) | 1998-06-26 | 2000-01-06 | Quanam Medical Corporation | Topoisomerase inhibitors for prevention of restenosis |
US6203812B1 (en) | 1998-06-29 | 2001-03-20 | Hydromer, Inc. | Hydrophilic polymer blends used to prevent cow skin infections |
US6369039B1 (en) | 1998-06-30 | 2002-04-09 | Scimed Life Sytems, Inc. | High efficiency local drug delivery |
CA2362338A1 (en) | 1998-07-30 | 2000-02-10 | Human Rt. | Pharmaceutically acceptable composition comprising an aqueous solution of paclitaxel and albumin |
US6547760B1 (en) * | 1998-08-06 | 2003-04-15 | Cardeon Corporation | Aortic catheter with porous aortic arch balloon and methods for selective aortic perfusion |
US6013092A (en) * | 1998-08-18 | 2000-01-11 | Baxter International Inc. | Folding of catheter-mounted balloons to facilitate non-rotational radial expansion of intraluminal devices |
US6299604B1 (en) | 1998-08-20 | 2001-10-09 | Cook Incorporated | Coated implantable medical device |
AU5687199A (en) | 1998-08-24 | 2000-03-14 | Global Vascular Concepts, Inc. | Use of anti-angiogenic agents for inhibiting vessel wall injury |
US6335029B1 (en) | 1998-08-28 | 2002-01-01 | Scimed Life Systems, Inc. | Polymeric coatings for controlled delivery of active agents |
US5922754A (en) | 1998-10-02 | 1999-07-13 | Abbott Laboratories | Pharmaceutical compositions containing paclitaxel |
EP1125396A2 (en) * | 1998-10-30 | 2001-08-22 | Certco Incorporated | Incorporating shared randomness into distributed cryptography |
US6017948A (en) | 1998-10-30 | 2000-01-25 | Supergen, Inc. | Water-miscible pharmaceutical compositions |
US6120533A (en) | 1998-11-13 | 2000-09-19 | Isostent, Inc. | Stent delivery system for a radioisotope stent |
WO2000032238A1 (en) * | 1998-12-03 | 2000-06-08 | Scimed Life Systems, Inc. | Stent having drug crystals thereon |
US6040330A (en) * | 1999-01-08 | 2000-03-21 | Bionumerik Pharmaceuticals, Inc. | Pharmaceutical formulations of taxanes |
US7780628B1 (en) | 1999-01-11 | 2010-08-24 | Angiodynamics, Inc. | Apparatus and methods for treating congestive heart disease |
MXPA01007651A (es) | 1999-01-28 | 2002-03-14 | Union Carbide Chem Plastic | Dispositivos medicos lubricos. |
US6419692B1 (en) | 1999-02-03 | 2002-07-16 | Scimed Life Systems, Inc. | Surface protection method for stents and balloon catheters for drug delivery |
WO2000047197A2 (en) | 1999-02-12 | 2000-08-17 | Quanam Medical Corporation | Alkylating agents for treatment of cellular proliferation |
US6191619B1 (en) * | 1999-08-24 | 2001-02-20 | Analog Devices, Inc. | Translators and methods for converting differential signals to single-ended signals |
US6790228B2 (en) * | 1999-12-23 | 2004-09-14 | Advanced Cardiovascular Systems, Inc. | Coating for implantable devices and a method of forming the same |
US6503954B1 (en) * | 2000-03-31 | 2003-01-07 | Advanced Cardiovascular Systems, Inc. | Biocompatible carrier containing actinomycin D and a method of forming the same |
US6706892B1 (en) | 1999-09-07 | 2004-03-16 | Conjuchem, Inc. | Pulmonary delivery for bioconjugation |
US6203551B1 (en) * | 1999-10-04 | 2001-03-20 | Advanced Cardiovascular Systems, Inc. | Chamber for applying therapeutic substances to an implant device |
CA2386007A1 (en) | 1999-10-06 | 2001-04-12 | The Penn State Research Foundation | System and device for preventing restenosis in body vessels |
US6682545B1 (en) | 1999-10-06 | 2004-01-27 | The Penn State Research Foundation | System and device for preventing restenosis in body vessels |
JP4613406B2 (ja) | 1999-11-05 | 2011-01-19 | 株式会社デンソー | 受光素子、距離測定装置及び距離・画像測定装置 |
US6616591B1 (en) * | 1999-12-08 | 2003-09-09 | Scimed Life Systems, Inc. | Radioactive compositions and methods of use thereof |
US6254921B1 (en) | 1999-12-08 | 2001-07-03 | Surmodics, Inc. | Coating process and apparatus |
US6719774B1 (en) | 1999-12-23 | 2004-04-13 | Advanced Cardiovascular Systems, Inc. | Method for forming low profile balloon and low profile balloon for use with a catheter |
WO2001049338A1 (en) | 1999-12-30 | 2001-07-12 | Li Wei Pin | Controlled delivery of therapeutic agents by insertable medical devices |
US6355058B1 (en) * | 1999-12-30 | 2002-03-12 | Advanced Cardiovascular Systems, Inc. | Stent with radiopaque coating consisting of particles in a binder |
WO2001049268A1 (en) | 2000-01-05 | 2001-07-12 | Imarx Therapeutics, Inc. | Pharmaceutical formulations for the delivery of drugs having low aqueous solubility |
US6575888B2 (en) | 2000-01-25 | 2003-06-10 | Biosurface Engineering Technologies, Inc. | Bioabsorbable brachytherapy device |
CA2396628A1 (en) | 2000-01-25 | 2001-08-02 | Edwards Lifesciences Corporation | Delivery systems for treatment of restenosis and anastomotic intimal hyperplasia |
JP4626005B2 (ja) * | 2000-01-27 | 2011-02-02 | 東洋紡績株式会社 | 血液適合性組成物およびそれを被覆した医療用具 |
WO2001076525A2 (en) | 2000-04-10 | 2001-10-18 | Advanced Cardiovascular Systems, Inc. | Selectively coated stent delivery system and method of manufacture thereof |
US6599448B1 (en) * | 2000-05-10 | 2003-07-29 | Hydromer, Inc. | Radio-opaque polymeric compositions |
US6585765B1 (en) | 2000-06-29 | 2003-07-01 | Advanced Cardiovascular Systems, Inc. | Implantable device having substances impregnated therein and a method of impregnating the same |
TWI257307B (en) | 2000-07-12 | 2006-07-01 | Orthologic Corp | Pharmaceutical composition for cardiac tissue repair |
EP1330273B1 (en) | 2000-10-31 | 2007-07-25 | Cook Incorporated | Coated implantable medical device |
US6635082B1 (en) | 2000-12-29 | 2003-10-21 | Advanced Cardiovascular Systems Inc. | Radiopaque stent |
US6544223B1 (en) * | 2001-01-05 | 2003-04-08 | Advanced Cardiovascular Systems, Inc. | Balloon catheter for delivering therapeutic agents |
US7179251B2 (en) * | 2001-01-17 | 2007-02-20 | Boston Scientific Scimed, Inc. | Therapeutic delivery balloon |
WO2002066092A2 (en) | 2001-02-23 | 2002-08-29 | Angiogene Inc. | Drug eluting device for treating vascular diseases |
DE10115740A1 (de) * | 2001-03-26 | 2002-10-02 | Ulrich Speck | Zubereitung für die Restenoseprophylaxe |
FR2823118B1 (fr) * | 2001-04-04 | 2004-03-19 | Lavipharm Lab Inc | Nouvelle composition filmogene a usage topique et son utilisation pour la delivrance d'agents actifs |
TWI288654B (en) * | 2001-05-17 | 2007-10-21 | Ind Tech Res Inst | Process for the purification of water-soluble non-ionic contrast agents |
JP4294470B2 (ja) | 2001-06-14 | 2009-07-15 | クック インコーポレイテッド | 脈管内フィルター |
CN100544713C (zh) * | 2001-09-13 | 2009-09-30 | 大化制药株式会社 | 化疗栓塞用紫杉醇的混合组合物、该组合物的油包水型乳剂及它们的制造方法 |
WO2003035135A1 (en) | 2001-09-24 | 2003-05-01 | Boston Scientific Limited | Optimized dosing for drug coated stents |
WO2003041686A2 (en) | 2001-11-14 | 2003-05-22 | Medlogic Global Limited | Improved therapy for topical diseases |
JP4527978B2 (ja) | 2001-12-03 | 2010-08-18 | ウニベルジテートスクリーニクム シャリテー デア フンボルト−ウニベルジテート ツー ベルリン テクノロジー トランスファーステラ | ポドフィロトキシン |
EP2324866B1 (en) | 2002-07-12 | 2014-06-18 | Cook Medical Technologies LLC | Angioplasty balloons drug-coated in an expanded condition |
PL375698A1 (en) | 2002-09-06 | 2005-12-12 | Abbott Laboratories | Medical device having hydration inhibitor |
DE10244847A1 (de) | 2002-09-20 | 2004-04-01 | Ulrich Prof. Dr. Speck | Medizinische Vorrichtung zur Arzneimittelabgabe |
US7060051B2 (en) * | 2002-09-24 | 2006-06-13 | Scimed Life Systems, Inc. | Multi-balloon catheter with hydrogel coating |
CA2444781A1 (en) | 2002-10-17 | 2004-04-17 | Rolf C. Hagen Inc. | Topical gel matrix |
US7491234B2 (en) * | 2002-12-03 | 2009-02-17 | Boston Scientific Scimed, Inc. | Medical devices for delivery of therapeutic agents |
US20040224003A1 (en) | 2003-02-07 | 2004-11-11 | Schultz Robert K. | Drug formulations for coating medical devices |
JP2005301328A (ja) * | 2003-07-10 | 2005-10-27 | Finalabo Co Ltd | 株式信用取引における顧客口座内全建玉について一律に実行する個別建玉ごとの指定率での損切り機能付き建玉管理システム、顧客口座内全株式について一律に実行する個別株式ごとの指定率での損切り機能付き所有株式管理システム、株式信用取引における顧客口座内全建玉について一律に実行する個別建玉ごとの指定の保証金維持率による損切り機能付き建玉管理システム |
US20050063926A1 (en) * | 2003-09-23 | 2005-03-24 | Bathina Harinath B. | Film-forming compositions for protecting animal skin |
ATE534424T1 (de) | 2004-03-19 | 2011-12-15 | Abbott Lab | Mehrfache arzneiabgabe aus einem ballon und eine prothese |
US7704545B2 (en) | 2004-05-12 | 2010-04-27 | Medtronic Vascular, Inc. | Drug-polymer coated stent |
US20060029720A1 (en) | 2004-08-03 | 2006-02-09 | Anastasia Panos | Methods and apparatus for injection coating a medical device |
ATE432955T1 (de) | 2005-12-05 | 2009-06-15 | Nitto Denko Corp | Polyglutamat-aminosäure-konjugate und verfahren |
US7919108B2 (en) | 2006-03-10 | 2011-04-05 | Cook Incorporated | Taxane coatings for implantable medical devices |
JP4892289B2 (ja) * | 2006-07-07 | 2012-03-07 | 株式会社日立製作所 | 複数のストレージ装置を含むストレージシステム |
US20080012034A1 (en) | 2006-07-17 | 2008-01-17 | 3M Innovative Properties Company | Led package with converging extractor |
US8414525B2 (en) | 2006-11-20 | 2013-04-09 | Lutonix, Inc. | Drug releasing coatings for medical devices |
US8425459B2 (en) | 2006-11-20 | 2013-04-23 | Lutonix, Inc. | Medical device rapid drug releasing coatings comprising a therapeutic agent and a contrast agent |
US20080175887A1 (en) | 2006-11-20 | 2008-07-24 | Lixiao Wang | Treatment of Asthma and Chronic Obstructive Pulmonary Disease With Anti-proliferate and Anti-inflammatory Drugs |
US8414526B2 (en) | 2006-11-20 | 2013-04-09 | Lutonix, Inc. | Medical device rapid drug releasing coatings comprising oils, fatty acids, and/or lipids |
EP2066321A2 (en) | 2006-11-20 | 2009-06-10 | Lutonix, Inc. | Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs |
DE102007003184A1 (de) * | 2007-01-22 | 2008-07-24 | Orlowski, Michael, Dr. | Verfahren zur Beladung von strukturierten Oberflächen |
-
2001
- 2001-03-26 DE DE10115740A patent/DE10115740A1/de not_active Ceased
- 2001-12-20 EP EP01990310A patent/EP1372737B8/de not_active Expired - Lifetime
- 2001-12-20 DE DE20122735U patent/DE20122735U1/de not_active Expired - Lifetime
- 2001-12-20 CN CN2006100998225A patent/CN1899614B/zh not_active Expired - Lifetime
- 2001-12-20 PL PL369006A patent/PL212008B1/pl unknown
- 2001-12-20 DE DE50110649T patent/DE50110649D1/de not_active Expired - Lifetime
- 2001-12-20 BR BRPI0116945A patent/BRPI0116945B8/pt not_active IP Right Cessation
- 2001-12-20 EP EP06001041A patent/EP1669092B1/de not_active Revoked
- 2001-12-20 PT PT01990310T patent/PT1372737E/pt unknown
- 2001-12-20 ES ES06001042T patent/ES2289721T3/es not_active Expired - Lifetime
- 2001-12-20 US US10/472,844 patent/US7750041B2/en not_active Expired - Lifetime
- 2001-12-20 DE DE20122736U patent/DE20122736U1/de not_active Expired - Lifetime
- 2001-12-20 IL IL15774101A patent/IL157741A0/xx unknown
- 2001-12-20 AT AT01990310T patent/ATE334703T1/de active
- 2001-12-20 DE DE50112978T patent/DE50112978D1/de not_active Expired - Lifetime
- 2001-12-20 DE DE50112886T patent/DE50112886D1/de not_active Expired - Lifetime
- 2001-12-20 DK DK06001042T patent/DK1666071T3/da active
- 2001-12-20 JP JP2002575021A patent/JP4484432B2/ja not_active Expired - Lifetime
- 2001-12-20 CZ CZ20032293A patent/CZ299953B6/cs not_active IP Right Cessation
- 2001-12-20 CN CNB2005101357996A patent/CN100379456C/zh not_active Expired - Fee Related
- 2001-12-20 CA CA2442080A patent/CA2442080C/en not_active Expired - Lifetime
- 2001-12-20 DK DK01990310T patent/DK1372737T3/da active
- 2001-12-20 DK DK06001040T patent/DK1666070T3/da active
- 2001-12-20 DE DE50115417T patent/DE50115417D1/de not_active Expired - Lifetime
- 2001-12-20 MX MXPA03008368A patent/MXPA03008368A/es active IP Right Grant
- 2001-12-20 PT PT06001040T patent/PT1666070E/pt unknown
- 2001-12-20 AT AT06001041T patent/ATE462450T1/de active
- 2001-12-20 HU HU0303598A patent/HUP0303598A3/hu not_active Application Discontinuation
- 2001-12-20 PT PT06001041T patent/PT1669092E/pt unknown
- 2001-12-20 AT AT06001040T patent/ATE372131T1/de active
- 2001-12-20 CN CN2006100998210A patent/CN1935277B/zh not_active Expired - Lifetime
- 2001-12-20 DE DE20122582U patent/DE20122582U1/de not_active Expired - Lifetime
- 2001-12-20 ES ES06001041T patent/ES2340407T3/es not_active Expired - Lifetime
- 2001-12-20 EP EP06001040A patent/EP1666070B1/de not_active Revoked
- 2001-12-20 AT AT06001042T patent/ATE369879T1/de active
- 2001-12-20 CN CN200610099823XA patent/CN1899615B/zh not_active Expired - Lifetime
- 2001-12-20 PT PT06001042T patent/PT1666071E/pt unknown
- 2001-12-20 CN CNB018230806A patent/CN1261165C/zh not_active Expired - Lifetime
- 2001-12-20 EP EP06001042A patent/EP1666071B1/de not_active Revoked
- 2001-12-20 DK DK06001041.0T patent/DK1669092T3/da active
- 2001-12-20 KR KR1020037012360A patent/KR100874308B1/ko active IP Right Grant
- 2001-12-20 ES ES06001040T patent/ES2289720T3/es not_active Expired - Lifetime
- 2001-12-20 ES ES01990310T patent/ES2269500T3/es not_active Expired - Lifetime
- 2001-12-20 WO PCT/DE2001/004782 patent/WO2002076509A2/de active IP Right Grant
- 2001-12-20 NZ NZ527825A patent/NZ527825A/en not_active IP Right Cessation
-
2003
- 2003-09-01 ZA ZA200306805A patent/ZA200306806B/xx unknown
- 2003-09-04 IL IL157741A patent/IL157741A/en unknown
-
2004
- 2004-09-17 HK HK04107122A patent/HK1064296A1/xx not_active IP Right Cessation
-
2006
- 2006-09-27 AU AU2006222699A patent/AU2006222699B2/en not_active Expired
- 2006-09-27 AU AU2006222702A patent/AU2006222702B2/en not_active Expired
- 2006-09-27 AU AU2006222697A patent/AU2006222697B2/en not_active Expired
- 2006-10-24 CY CY20061101532T patent/CY1105727T1/el unknown
- 2006-11-30 HK HK06113145.1A patent/HK1092377A1/xx not_active IP Right Cessation
-
2007
- 2007-02-28 AT AT0012007U patent/AT9810U1/de not_active IP Right Cessation
- 2007-03-01 AT AT0012807U patent/AT10200U1/de not_active IP Right Cessation
- 2007-03-19 HK HK07102893.7A patent/HK1095740A1/xx not_active IP Right Cessation
- 2007-05-04 HK HK07104751.4A patent/HK1098354A1/xx not_active IP Right Cessation
- 2007-06-14 US US11/763,125 patent/US20080102034A1/en not_active Abandoned
- 2007-06-14 US US11/763,116 patent/US20080102033A1/en not_active Abandoned
- 2007-07-03 HK HK07107058.7A patent/HK1099713A1/xx not_active IP Right Cessation
- 2007-11-14 CY CY20071101478T patent/CY1107009T1/el unknown
- 2007-12-04 CY CY20071101549T patent/CY1107032T1/el unknown
-
2010
- 2010-06-25 CY CY20101100588T patent/CY1110918T1/el unknown
- 2010-07-13 US US12/835,414 patent/US9066990B2/en not_active Expired - Fee Related
- 2010-07-13 US US12/835,420 patent/US8389043B2/en not_active Expired - Lifetime
-
2014
- 2014-04-17 US US14/255,316 patent/US20140227192A1/en not_active Abandoned
- 2014-04-17 US US14/255,359 patent/US20140227193A1/en not_active Abandoned
- 2014-04-17 US US14/255,392 patent/US20140227194A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0116945A (pt) | Uma preparação para prevenção de restenose | |
US5510391A (en) | Method of treating blood vessel disorders of the skin using vitamin K | |
CO5271759A1 (es) | Formulacion en solucion que contiene una mezcla de disolventes | |
BR0111186A (pt) | Uso de composição de celecoxib para rápido alìvio de dor | |
BR0012136A (pt) | Inibidores de reabsorção de norepinefrina altamente seletivos e métodos de uso dos mesmos | |
BR9908488A (pt) | Composição farmacêutica de topiramato | |
BR9906372A (pt) | Composição farmaceutica aquosa para aplicação na mucosa | |
YU215090A (sr) | Formulacija u obliku pilule za kontrolisano oslobađanje | |
BR0107157A (pt) | Diagnose e tratamento de condições cardiovasculares | |
KR950703972A (ko) | 항혈전성 치료 및 암 예방을 위한 아세틸살리실산을 함유하는 경피 투여 시스템(transdermal administration system containing acetylsalicyliic acid for antithrombotic therapy and the prevention of cancer) | |
WO2008047680A1 (fr) | Préparation externe pour la peau | |
BRPI0414500A (pt) | formulação farmacêutica composição para tratar uma infecção vaginal, e, métodos para tratar uma infecção vaginal, para estabilizar uma formulação de clindamicina, para tratar ou prevenir uma recorrência de uma infecção vaginal em uma paciente e para tratar condições vaginais | |
KR100233770B1 (ko) | 피부통과 투약을 위한 약제학적 조성물 | |
BR0114272A (pt) | Formulação farmacêutica de liberação prolongada independente da força iÈnica | |
BR0008713A (pt) | Processos para preparar formulações ecomposições farmacêuticas orais com ecb | |
WO1997039746A1 (en) | Method of and composition for treating disorders of the skin using vitamin k | |
BR0013625A (pt) | Composição para uso no tratamento de carcinoma hepatocelular | |
Chin et al. | The action of activated charcoal on poisons in the digestive tract | |
MXPA02011472A (es) | Combinacion farmaceutica de bicalutamida y tamoxifeno para proporcionar un efecto anti-androgenico y un efecto anti-estrogenico. | |
BR0313714A (pt) | Composição oral de tolterodina lìquida | |
BR0212744A (pt) | Formulações de cisplatina de toxicidade reduzida e métodos para uso das mesmas | |
Chernish et al. | Adsorption of propoxyphene hydrochloride by activated charcoal | |
BR0012775A (pt) | Comprimido de microgrânulos com baixa dosagem de princìpio ativo contendo um diluente diretamente compressìvel, composição, e, processo de preparação do comprimido | |
FI946057A0 (fi) | Paikalliseen käyttöön tarkoitettu valmiste | |
JPH03120230A (ja) | 薬効成分の経皮吸収促進剤及び経皮吸収型製剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] |
Free format text: DE ACORDO COM O ART.34 "II" DA LPI (LEI 9279, DE 14/05/96), O EXAME FICA SUSPENSO PARA QUE O REQUERENTE APRESENTE DOCUMENTOS NECESSARIOS A REGULARIZACAO DO PROCESSO E EXAME DO PEDIDO. |
|
B25A | Requested transfer of rights approved |
Owner name: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) Free format text: TRANSFERIDO DE: ULRICH SPECK |
|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B25D | Requested change of name of applicant approved |
Owner name: BAYER PHARMA AKTIENGESELLSCHAFT (DE) |
|
B25A | Requested transfer of rights approved |
Owner name: BAYER INTELLECTUAL PROPERTY GMBH. (DE) |
|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 08/12/2015, OBSERVADAS AS CONDICOES LEGAIS. |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 20/12/2001 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |
|
B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 21A ANUIDADE. |
|
B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2703 DE 25-10-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |